BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19934659)

  • 21. [Prolyl isomerase pin1 protecting against aging diseases].
    Uchida T; Fanghaenel J; Uchida C; Ostroff L
    Tanpakushitsu Kakusan Koso; 2005 Sep; 50(11):1413-9. PubMed ID: 16146189
    [No Abstract]   [Full Text] [Related]  

  • 22. The amplifier effect: how Pin1 empowers mutant p53.
    Hu H; Wulf GM
    Breast Cancer Res; 2011 Oct; 13(5):315. PubMed ID: 22017796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
    Kim JH; Jung JH; Kim SH; Jeong SJ
    Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
    Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
    Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BTG2 antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence.
    Wheaton K; Muir J; Ma W; Benchimol S
    Aging Cell; 2010 Oct; 9(5):747-60. PubMed ID: 20569234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
    Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
    J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors.
    Brenkman AB; de Keizer PL; van den Broek NJ; van der Groep P; van Diest PJ; van der Horst A; Smits AM; Burgering BM
    Cancer Res; 2008 Sep; 68(18):7597-605. PubMed ID: 18794148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pin1 flips Alzheimer's switch.
    Etzkorn FA
    ACS Chem Biol; 2006 May; 1(4):214-6. PubMed ID: 17163675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery).
    Brazhnik P; Kohn KW
    Math Biosci; 2007 Nov; 210(1):60-77. PubMed ID: 17585950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association.
    Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY
    Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
    Yang L; Song T; Cheng Q; Chen L; Chen J
    Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of low and high doses of Taxol in anaplastic thyroid cancer cells: possible implication of the Pin1 prolyl isomerase.
    Pushkarev VM; Starenki DV; Saenko VA; Pushkarev VV; Kovzun OI; Tronko MD; Popadiuk ID; Yamashita S
    Exp Oncol; 2008 Sep; 30(3):190-4. PubMed ID: 18806740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some p53-binding proteins that can function as arbiters of life and death.
    Braithwaite AW; Del Sal G; Lu X
    Cell Death Differ; 2006 Jun; 13(6):984-93. PubMed ID: 16575404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
    Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
    Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.